TP53 and Complex Karyotype Represent a Very High-Risk Group in Myelofibrosis Undergoing Hematopoietic Stem Cell Transplantation: An International Collaborative Analysis
Year: 2022
Type: conference-abstract
Source: Blood
Authors: Nico Gagelmann, Anita Badbaran, Rachel Beth Salit, Thomas Schroeder, Carmelo Gurnari, Simona Pagliuca, Arnold Ganser, Christina Rautenberg, Bruno Cassinat, Felicitas R Thol, Christine Wolschke, Marie Robin, Michael Heuser, Marie Thérèse Rubio, Jaroslaw P. Maciejewski, Hans Christian Reinhardt, Bart L. Scott, Nicolaus Kroeger
Institutions: University Medical Center Hamburg-Eppendorf, Fred Hutch Cancer Center, Essen University Hospital, Cleveland Clinic, Centre Hospitalier Régional et Universitaire de Nancy, Medizinische Hochschule Hannover, Inserm, Institut de recherche Saint-Louis, Hématopoïèse normale et pathologique : Emergence, environnement et recherche translationnelle, Hôpital Saint-Louis
Language: English
Subfield: Genetics
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W4310126196